Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Capital Expenditures: 2019-2024

Historic Capital Expenditures for LifeStance Health (LFST) over the last 5 years, with FY2024 value amounting to $21.6 million.

  • LifeStance Health's Capital Expenditures rose 10374.18% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.4 million, marking a year-over-year increase of 5897.69%. This contributed to the annual value of $21.6 million for FY2024, which is 4677.69% down from last year.
  • Per LifeStance Health's latest filing, its Capital Expenditures stood at $21.6 million for FY2024, which was down 4677.69% from $40.5 million recorded in FY2023.
  • LifeStance Health's Capital Expenditures' 5-year high stood at $94.5 million during FY2021, with a 5-year trough of $21.6 million in FY2024.
  • For the 4-year period, LifeStance Health's Capital Expenditures averaged around $59.0 million, with its median value being $59.9 million (2022).
  • As far as peak fluctuations go, LifeStance Health's Capital Expenditures crashed by 1612.52% in 2022, and later plummeted by 4887.39% in 2023.
  • LifeStance Health's Capital Expenditures (Annual) stood at $94.5 million in 2021, then fell by 16.13% to $79.3 million in 2022, then crashed by 48.87% to $40.5 million in 2023, then tumbled by 46.78% to $21.6 million in 2024.
  • Its Capital Expenditures stands at $21.6 million for FY2024, versus $40.5 million for FY2023 and $79.3 million for FY2022.